8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 22, 2026 · 8d ago · Accession 0001193125-26-277653
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Eledon Pharmaceuticals, Inc.
- Ticker
- ELDN
- CIK
- 1404281
- Form type
- 8-K
- Filing date
- Jun 22, 2026
- Report date
- Jun 18, 2026
- Document
- eldn-20260618.htm
- Size
- 189 KB